Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 82

Related Citations for PubMed (Select 24046389)

1.

Inflammatory breast cancer: yet another risk of the obesity epidemic?

Amiri-Kordestani L, Kamangar F, Zujewski JA.

J Natl Cancer Inst. 2013 Sep 18;105(18):1340-2. doi: 10.1093/jnci/djt236. No abstract available.

2.

Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies.

Enger SM, Ross RK, Paganini-Hill A, Carpenter CL, Bernstein L.

Cancer Epidemiol Biomarkers Prev. 2000 Jul;9(7):681-7.

3.

Risk factors according to estrogen receptor status of breast cancer patients in Trivandrum, South India.

Dey S, Boffetta P, Mathews A, Brennan P, Soliman A, Mathew A.

Int J Cancer. 2009 Oct 1;125(7):1663-70. doi: 10.1002/ijc.24460.

PMID:
19452528
4.

Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer.

Dignam JJ, Wieand K, Johnson KA, Fisher B, Xu L, Mamounas EP.

J Natl Cancer Inst. 2003 Oct 1;95(19):1467-76.

5.

Relation between steroid receptor status and body weight in breast cancer patients.

Giuffrida D, Lupo L, La Porta GA, La Rosa GL, Padova G, Foti E, Marchese V, Belfiore A.

Eur J Cancer. 1992;28(1):112-5.

PMID:
1567660
6.

Body-size indicators and risk of breast cancer according to menopause and estrogen-receptor status.

Männistö S, Pietinen P, Pyy M, Palmgren J, Eskelinen M, Uusitupa M.

Int J Cancer. 1996 Sep 27;68(1):8-13.

PMID:
8895532
7.

Association of breast cancer subtypes and body mass index.

Petekkaya I, Sahin U, Gezgen G, Solak M, Yuce D, Dizdar O, Arslan C, Ayyildiz V, Altundag K.

Tumori. 2013 Mar-Apr;99(2):129-33. doi: 10.1700/1283.14180.

PMID:
23748802
8.

Lifetime adult weight gain, central adiposity, and the risk of pre- and postmenopausal breast cancer in the Western New York exposures and breast cancer study.

Han D, Nie J, Bonner MR, McCann SE, Muti P, Trevisan M, Ramirez-Marrero FA, Vito D, Freudenheim JL.

Int J Cancer. 2006 Dec 15;119(12):2931-7.

PMID:
17016824
9.

The effect of body mass index and oestrogen receptor level on survival of breast cancer patients.

Newman SC, Lees AW, Jenkins HJ.

Int J Epidemiol. 1997 Jun;26(3):484-90.

10.

Association of increased body mass index with diminished tumor estrogen receptor (ER) level in breast cancer patients younger than 50 years of age with ER-positive tumors.

Lehrer S, Levine E, Savoretti P, Cropley J, Song HK, Mandell LR, Shank B.

Cancer. 1991 Dec 1;68(11):2489. No abstract available.

PMID:
1933787
11.

Postmenopausal obesity as a breast cancer risk factor according to estrogen and progesterone receptor status (Japan).

Yoo K, Tajima K, Park S, Kang D, Kim S, Hirose K, Takeuchi T, Miura S.

Cancer Lett. 2001 Jun 10;167(1):57-63.

PMID:
11323099
12.

Body weight and prognostic indicators in breast cancer. Modifying effect of estrogen receptors.

Verreault R, Brisson J, Deschênes L, Naud F.

Am J Epidemiol. 1989 Feb;129(2):260-8.

PMID:
2912039
13.

A retrospective review of the metabolic syndrome in women diagnosed with breast cancer and correlation with estrogen receptor.

Colonna SV, Douglas Case L, Lawrence JA.

Breast Cancer Res Treat. 2012 Jan;131(1):325-31. doi: 10.1007/s10549-011-1790-x. Epub 2011 Oct 2.

PMID:
21964613
14.

Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer.

Dignam JJ, Wieand K, Johnson KA, Raich P, Anderson SJ, Somkin C, Wickerham DL.

Breast Cancer Res Treat. 2006 Jun;97(3):245-54. Epub 2005 Dec 6.

PMID:
16331345
15.

Leisure-time physical activity and breast cancer risk defined by estrogen and progesterone receptor status--the Japan Public Health Center-based Prospective Study.

Suzuki R, Iwasaki M, Yamamoto S, Inoue M, Sasazuki S, Sawada N, Yamaji T, Shimazu T, Tsugane S; Japan Public Health Center-based Prospective Study Group.

Prev Med. 2011 Mar-Apr;52(3-4):227-33. doi: 10.1016/j.ypmed.2011.01.016. Epub 2011 Feb 2.

PMID:
21295062
16.

Empirically derived dietary patterns and risk of postmenopausal breast cancer in a large prospective cohort study.

Velie EM, Schairer C, Flood A, He JP, Khattree R, Schatzkin A.

Am J Clin Nutr. 2005 Dec;82(6):1308-19.

17.

Interactions between body mass index and hormone therapy and postmenopausal breast cancer risk (United States).

Li CI, Malone KE, Daling JR.

Cancer Causes Control. 2006 Jun;17(5):695-703.

PMID:
16633917
18.
19.

Estrogen and progesterone receptors in breast cancer patients. Epidemiologic characteristics and survival differences.

Ruder AM, Lubin F, Wax Y, Geier A, Alfundary E, Chetrit A.

Cancer. 1989 Jul 1;64(1):196-202.

PMID:
2731116
20.

Genetic and environmental predictors, endogenous hormones and growth factors, and risk of estrogen receptor-positive breast cancer in Japanese women.

Yoshimoto N, Nishiyama T, Toyama T, Takahashi S, Shiraki N, Sugiura H, Endo Y, Iwasa M, Fujii Y, Yamashita H.

Cancer Sci. 2011 Nov;102(11):2065-72. doi: 10.1111/j.1349-7006.2011.02047.x. Epub 2011 Aug 24.

PMID:
21790896
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk